PATENT CLAIM ANALYSIS

Application Number: 15938961
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "130100"]

Abstract:
The present invention relates to anti-AXL antibodies, immunoconjugates, compositions and method of treatment of cancer with such anti-AXL antibodies, immunoconjugates, or compositions.

Claim (Index 9):
The bispecific antibody of  claim 7 , wherein the amino acid in the position corresponding to K409 in a human IgG1 heavy chain is R in said first heavy chain, and the amino acid in the position corresponding to F405 in a human IgG1 heavy chain is L in said second heavy chain, or vice versa.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.42105
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15325364', '15533049', '15318023', '15318028', '14355986']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.771863298227844
- 35 USC 102 Novelty (BERT): 0.6319536698768521
- Combined Prediction Score: 0.7578723353927449
- Mean Citation Score: 488.148804
- Max Citation Score: 670.65137
- Similarity Product: 508.35574802974463

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test